The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
See JNCCN.org for supplemental online content.
WickerhamDLO'ConnellMJConstantinoJP. The half century of clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP). Semin Oncol2008;35:522–529.
GradisharWJAndersonBOBalassanianR. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2017. Accessed November 1 2017. To view the most recent version of these guidelines visit NCCN.org.
PopescuISchragDAngAWongM. Racial/Ethnic and socioeconomic differences in colorectal and breast cancer treatment quality: the role of physician-level variations in care. Med Care2016;54:780–788.
LeMastersTJMadhavanSSSambamoorthiUVyasAM. Disparities in the initial local treatment of older women with early-stage breast cancer: a population-based study. J Womens Health (Larchmt)2017;26:735–744.
CamachoFTTanXAlcaláHE. Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in Medicare breast cancer survivors. Medicine (Baltimore)2017;96:e7147.
LautnerMLinHShenY. Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg2015;150:778–786.
WittayanukornSQianJWestrickSC. Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments. Res Social Adm Pharm2015;11:708–720.
InwaldECOrtmannOKollerM. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat2017;163:119–130.
MackeyRVChandru KowdleyG. Treatment practices and outcomes of elderly women with breast cancer in a community hospital. Am Surg2014;80:714–719.
HughesKSchnaperLBerryD. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med2004;351:971–977.
HughesKSSchnaperLABellonJR. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol2013;31:2382–2387.
MussHBWoolfSBerryD. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA2005;293:1073–1081.
DaughertyECDaughertyMRBogartJAShapiroA. Adjuvant radiation improves survival in older women following breast-conserving surgery for estrogen receptor-negative breast cancer. Clin Breast Cancer2016;16:500–506.e2.
Reeder-HayesKPeacock HintonSMengK. Disparities in use of human epidermal growth hormone receptor 2-targeted therapy for early-stage breast cancer. J Clin Oncol 2016;10;34:2003–2009.
SchonbergMMarcantonioELiD. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol2010;28:2038–2045.
LuuCGoldsteinLGoldnerB. Trends in radiotherapy after breast-conserving surgery in elderly patients with early-stage breast cancer. Ann Surg Oncol2013;20:3266–3273.
TuttleTMJarosekSHabermannEB. Omission of radiation therapy after breast-conserving surgery in the United States. A population-based analysis of clinicopathologic factors. Cancer2012;118:2004–2013.
WollschlägerDMengXWöckelA. Comorbidity-dependent adherence to guidelines and survival in breast cancer—is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J2018;24:120–127.
HowlanderNNooneAMKrapchoM eds. SEER Cancer Statistics Review 1975-2012National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975_2011/. Accessed September 22 2015.
EngelsEAPfeifferRMRickerW. Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol2011;174:860–870.
National Cancer Institute. Division of Cancer Control & Population Sciences. Healthcare Delivery Research Program. SEER-Medicare: About the Data Files. Available at: http://appliedresearch.cancer.gov/seermedicare/aboutdata/. Accessed September 22 2015.
U.S. Health Resources and Services Administration. Bureau of Health Professions. Area Resource File 2009-2010 Release. Rockville, MD: U.S. Department of Health and Human Services; Fairfax, VA: Quality Resource Systems, Inc; 2010. Codebook: HE-001.
DeschCMcNiffKSchneiderE. American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol2008;26:3631–3637.
FreedmanRAVirgoKSHeY. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer2010;117:180–189.
Working Group on Health Outcomes for Older Persons with Multiple Chronic Conditions. Universal health outcome measures for older persons with multiple chronic conditions. J Am Geriatr Soc2012;60:2333–2341.
LoggersETBuistDSGoldLS. Advanced imaging and receipt of guideline concordant care in women with early stage breast cancer. Int J Breast Cancer2016;2016:2182985.
MerrillAYBrownDRKlepinHD. Outcomes after mastectomy and lumpectomy in octogenarians and nonagenarians with early-stage breast cancer. Am Surg2017;83:887–894.
HurriaAWongLVillalunaD. Role of age and health in treatment recommendations for older adults with breast cancer: the perspective of oncologists and primary care providers. J Clin Oncol2008;26:5386–5392.
WitherbySMMussHB. Managing early-stage breast cancer in your older patients. Oncology (Williston Park)2006;20:1003–1012; discussion 1012–1013 1017–1018.
JonesELLeakAMussHB. Adjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes. Oncology (Williston Park)2013;26:793–801.
HamelinckVCBastiaannetEPieterseAH. A prospective comparison of younger and older patients' preferences for adjuvant chemotherapy and hormonal therapy in early breast cancer. Clin Breast Cancer2016;16:379–388.
WallwienerCWHartkopfADGrabeE. Adjuvant chemotherapy in elderly patients with primary breast cancer: are women ≥65 undertreated?J Cancer Res Clin Oncol2016;142:1847–1853.
KlepinHDPitcherBNBallmanKV. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance). J Oncol Pract2014;10:e285–292.
de la Morena BarrioPConesaMÁGonzález-BillalabeitiaE. Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Canc Netw2015;13:417–423.